• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Catalog Number 4122201
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Tachycardia (2095); Diaphoresis (2452)
Event Date 01/18/2023
Event Type  Injury  
Event Description
The customer reported an incident where the patient had an adverse reaction during a therapeutic plasma exchange (tpe) procedure which required a medical intervention.Per the customer, the replacement fluid used was fresh frozen plasma.The patient's heart rate went up and blood pressure dropped and it was reported that the patient became diaphoretic approximately 1 hour into the procedure.The physician was notified and the patient was given 650 mg tylenol per oral, 25 mg ivp benadryl, 4 mg ivp zofran and 2 gm ivp calcium gluconate.They had to call a rapid response.Per the customer, the patient was stable and fine.The exchange set is not available for return for evaluation.
 
Manufacturer Narrative
Investigation: according to therapeutic apheresis: a physician's handbook, adverse events occur during therapeutic procedures with a frequency of 4.8%.Symptoms of these allergic reactions may include hives, dyspnea, wheezing, burning eyes, tachycardia, hypotension, and or facial swelling and flushing.Mild reactions can be treated with diphenhydramine administered through an iv.The device history records (dhr) were reviewed for this lot.There were no events noted in the dhr that would have contributed to the patient reaction experienced by the customer.A disposable complaint history search was performed for this lot and found no reports for similar issues on this lot.Root cause: based on the clinical findings and the patient symptomatology, the cause for the patient's reaction is believed to be related to an allergy to the replacement solution, fresh frozen plasma.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key16356890
MDR Text Key309322617
Report Number1722028-2023-00054
Device Sequence Number1
Product Code GKT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK150251
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/10/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number4122201
Device Lot Number2211156141
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/18/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age38 YR
Patient SexMale
Patient Weight90 KG
-
-